AstraZeneca's drug was tested in collaboration with Pfizer's drug.
1 report, 1 independent
Updated Sep 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
AstraZeneca's drug was tested in collaboration with Pfizer's drug.
Who's involved
What this event is mainly aboutKeep exploring
Part of
Major pharmaceutical companies, including Pfizer, AstraZeneca, and Merck, announced several new partnerships and acquisitions in the oncology sector.Also in this story
- Pfizer acquired Seagen for its cancer drug candidates, while a separate deal with Innovent helps offset revenue decline.
- Certara and Merck announced an expansion of their clinical technology collaboration, which began on July 8, 2025.
The entities involved
-
AstraZeneca
British-Swedish pharmaceutical company
Related events
- Alnylam Pharmaceuticals announced new partnerships with AstraZeneca for drug development and with Ionis Pharmaceuticals for clinical trials.
- AstraZeneca released a press release citing Dr. Frank Sciurba.
- AstraZeneca discontinued the eVOLVE-Lung02 trial on August 18, 2026.
- Amgen acquired Horizon Therapeutics, a company whose portfolio included a drug discovered by AstraZeneca.
- A drug status update affecting Australian patients involves Ipsen and AstraZeneca, with changes made to the Pharmaceutical Benefits Scheme (PBS) on September 1, 2026.